Skip to main content

Applera Board Okays Applied Biosystems Stock Buyback

NEW YORK, Aug. 29 (GenomeWeb News) – Applied Biosystems said today that its repurchase of up to $200 million of its common stock has been approved by the board of directors of its parent firm, Applera.

Foster City, Calif.-based Applied Biosystems said that the authorization supplements its existing authority to replenish shares issued under its employee stock benefits plan. The authorization has no time restrictions, the company added, and calls for the stock buyback to be made at times and prices management deems appropriate through open market purchases, privately negotiated transactions, tender offers, exchange offers, or otherwise.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.